Gastrointestinal Drugs Market to Grow at 4.90% CAGR by 2024, due to Growing Investment for Development of Novel Drugs, TMR Observes

Friday, October 5, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

ALBANY, New York, October 5, 2018 /PRNewswire/ --

According to the TMR, the gastrointestinal drugs market was

valued at US$45.5 bn in 2015 and expected to reach the value of US$61.6 bn by the end of 2024 by expanding with the CAGR of 4.90% over the forecast years from 2016 to 2024. Based on the drug
class, the gastrointestinal drugs market is dominated by the acid neutralizers and expected to remain dominant over the forecast period. Based on the region, the global market for gastrointestinal drugs dominated by North America with 41% shares in 2016 and expected to remain dominant by the end of predicted years. However, Asia Pacific is expected to grow with faster CAGR over the forecast period.

     (Logo: )

Get PDF Brochure for Research Insights at

Rising Government Initiatives and Investment to Boost Growth 

According to the World Gastroenterology Organization, 15 to 25% of the people globally are suffering from gastro-esophageal reflux disease (GERD). This is a key factor in boosting the need for the gastrointestinal drugs and likely to propel the growth of the global gastrointestinal drugs market. Growing awareness about the disease and increasing availability of treatments is boosting adoption of the gastrointestinal drugs and likely to fuel the growth of the global gastrointestinal drugs market. Additionally, growing investments in research and development (R&D) activities for the development of novel drugs are further expected to fuel the growth of the global gastrointestinal drugs market.  

Request a Custom Report at

Moreover, growing geriatric population in the emerging economies is leading to surg the number of the patients suffering from gastrointestinal diseases which are further fuelling the growth of the global gastrointestinal drugs market. In addition, numerous initiatives are taken by the Centers for Disease Control and Prevention (CDC) in order to promote cancer screening globally is fuelling the growth of the gastrointestinal drugs market. Also, The Division of Cancer Prevention and Control (DCPC) supports National Colorectal Cancer Action Campaign (NCCCP) are increasingly providing funds for research studies. The development and launch of the new improved products are fuelling growth of the global gastrointestinal drugs market.

Request a Sample of Report at

Lack of Novel Drugs for Treatment to Restrain Growth  

Despite these growth possibilities, lack of a permanent cure for gastrointestinal diseases is posing as a challenge to the growth of the global gastrointestinal drugs market. Additionally, etiology of irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are limiting growth of the global market. Nevertheless, the consistent technological advancements due to higher investment in the research and development (R&D) activities for development activities of treatment therapies of gastrointestinal diseases are projected to create lucrative opportunities for growth over the forecast period.

Request for Discount on This Report at

The global gastrointestinal drugs market has a strongly consolidated vendor landscape, observes Transparency Market Research (TMR). Top three players operating in the gastrointestinal drugs market such as Valeant Pharmaceuticals Inc., Janssen Biotech Inc., and Takeda Pharmaceutical collectively accounted for 61% in 2016. Some of the other players operating in the global gastrointestinal drugs market are Abbott Laboratories, Allergan Plc, AstraZeneca, Bayer AG, and Boehringer Ingelheim GmbH. The market is moderately competitive for now but, the degree of competition is expected to increase over the forecast period.

Browse Press Release at

This information is from the new report by TMR, titled "Gastrointestinal Drugs Market (Drug Class - Acid Neutralizers (Antacids, H2 Antagonists, and Proton Pump Inhibitors), Antidiarrheal and Laxatives, Antiemetic and Antinauseants, Anti-inflammatory Drugs, Biologics, and Antispasmodic; Route of Administration - Oral, Parenteral and Rectal; Disorder Type - Gastro-esophageal Reflux Disease, Inflammatory Bowel Disease, and Irritable Bowel Syndrome; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024."

Browse More Pharmaceutical Market Research Reports

Popular Research Reports by TMR: 

  • Rheumatoid Arthritis Drugs Market (Drug Type - Disease-modifying Anti-rheumatic Drugs (DMARDs), Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Biologic Response Modifiers (Biologics); Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy):
  • Thrombosis Drugs Market (Drug Class - Factor Xa Inhibitor, Low Molecular Weight Heparin, P2Y12 Platelet Inhibitor; Indication - Pulmonary Embolism, Atrial Fibrillation, Deep Vein Thrombosis; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
  • Erectile Dysfunction (ED) Drugs Market (Drug - Viagra, Cialis, Staxyn/Levitra, Stendra/Spedra; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies):

About Us 

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Mr. Rohit Bhisey Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email:  

Website:  Research Blog:

SOURCE Transparency Market Research

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store